[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350703-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350703-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-pivotal-role-of-scd1-in-digestive-cancers-bridging-lipid-metabolic-reprogramming-and-programmed-cell-death","The pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death","","Stearoyl‑CoA desaturase‑1 (SCD1) links lipid metabolic reprogramming to the regulation of cell death in digestive malignancies. Frequently overexpressed in gastric, liver, and colorectal cancers, SCD1 is proposed as a promising therapeutic target. This review details how SCD1 controls ferroptosis, autophagy, and apoptosis through lipid‑modifying functions, promoting malignant progression and influencing therapy resistance. Preclinical strategies targeting SCD1 are summarized, including monotherapy and combination approaches with ferroptosis inducers and anticancer agents, and future directions for drug development and clinical translation are discussed.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-pivotal-role-of-scd1-in-digestive-cancers-bridging-lipid-metabolic-reprogramming-and-programmed-cell-death/350703/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-pivotal-role-of-scd1-in-digestive-cancers-bridging-lipid-metabolic-reprogramming-and-programmed-cell-death/350703.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SCD1 play in digestive cancers?","Question",{"text":63,"@type":64},"SCD1 is a key nexus connecting lipid metabolic reprogramming to the regulation of cell death, and it is frequently overexpressed in digestive system malignancies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which regulated cell death pathways are discussed in relation to SCD1?",{"text":68,"@type":64},"The review describes SCD1’s influence on ferroptosis, autophagy, and apoptosis, linking lipid modification to tumor progression and therapy resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"How are SCD1-targeting therapies currently approached in preclinical research?",{"text":72,"@type":64},"Preclinical strategies include both monotherapy and combination approaches that pair SCD1 targeting with ferroptosis inducers, chemotherapeutic agents, or targeted drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350703,1790315708,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","INTERNATIONAL JOURNAL OF ONCOLOGY 69: 112, 2026  \nThe pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death (Review)  \nYANGXI FU 1,2 , ZHENG WANG2 , LIN LIU2 and XUDONG TANG2  \n1Graduate School, Beijing University of Chinese Medicine, Beijing 100029, P.R. China; 2Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, P.R. China  \nReceived March 29, 2026; Accepted July 1, 2026  \nDOI: 10.3892/ijo.2026.5925  \nAbstract. Stearoyl‑CoA desaturase‑1 (SCD1) has emerged asa critical nexus linking lipid metabolic reprogramming to the regulation of cell death. Frequently overexpressed in digestive system malignancies ‑ including gastric, liver and colorectal cancers ‑ SCD1 represents a promising therapeutic target. This review systematically examined how SCD1, through its lipid‑modifying functions, governs three key forms of regulated cell death ‑ ferroptosis, autophagy and apoptosis ‑ thereby driving malignant progression and mediating therapy resistance in digestive cancers. Building on this mechanistic framework, the specific contributions of these regulatory pathways to tumor biology and their association with drug resistance were delineated. Current preclinical therapeutic strategies targeting SCD1 were then highlighted, encom‑ passing both monotherapy and combination approaches with ferroptosis inducers, chemotherapeutic agents or targeted drugs. Finally, key challenges and outline future directions for drug development and clinical translation in this rapidly evolving field were discussed.  \nContents  \n1. Introduction  \n2. Metabolic cornerstone: SCD1‑mediated lipid reprogramming  \n3. SCD1: The regulator of lipid metabolism  \n4. SCD1 in digestive tumors: Oncogenic mechanisms  \n5. Combination therapy strategies targeting SCD1  \n6. Current status and challenges of clinical translation  \n7. Future prospects  \nCorrespondence to: Professor Xudong Tang, Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, 1 Xiyuan Caochang, Haidian, Beijing 100091, P.R. China  \nE‑mail: [txdly@sina.com](txdly@sina.com)  \nKey words: stearoyl‑CoA desaturase‑1, lipid metabolic reprogramming, ferroptosis, autophagy, apoptosis, digestive cancers  \n1. Introduction  \nDigestive cancers ‑ including gastric, esophageal, colorectal, liver and pancreatic malignancies ‑ account for a substantial proportion of the global cancer burden. According to the latest Global Burden of Disease data, the incidence and mortality rates of these malignancies rank among the highest of all tumor types (1) . Although the global incidence of gastric cancer (GC) has declined in recent decades (2,3), the disease burden associated with colorectal cancer (CRC), liver, pancreatic and esophageal cancers (EC) is projected to increase in the coming years (4‑7) . Furthermore, a rising incidence of early‑onset digestive cancers (occurring in individuals \u003C50 years of age), particularly GC and CRC, has been observed across multiple countries (3,8), with a more pronounced increase among males. More concerning, however, is that the five‑year survival rate for certain digestive cancers, such as pancreatic cancer, remains low (9) . Despite advances in early diagnosis and comprehensive treatment, drug resistance, metastasis and tumor recurrence persist as core clinical challenges, rendering digestive cancers a major and enduring public health problem.  \nMetabolic reprogramming is a hallmark of tumorigen‑ esis (10) . Unlike normal cells, tumor cells not only rely on aberrant glucose metabolism (e.g. , the Warburg effect) but also exhibit heightened dependence on lipid metabolism . Lipid metabolism reprogramming has thus emerged as a hallmark of digestive cancers and a critical driver of their malignant progression . Within this intricate metabolic network, stearoyl‑CoA desaturase‑1 (SCD1) plays a pivotal role, primarily functioning to maintain cellular lip","cbCaiuNPUlXpIAAS","https://ap.wps.com/l/cbCaiuNPUlXpIAAS","pdf",2608559,21,"English","# Contents\n## Introduction\n## Metabolic cornerstone: SCD1‑mediated lipid reprogramming\n## SCD1: The regulator of lipid metabolism\n## SCD1 in digestive tumors: Oncogenic mechanisms\n## Combination therapy strategies targeting SCD1\n## Current status and challenges of clinical translation\n## Future prospects","[{\"question\":\"What role does SCD1 play in digestive cancers?\",\"answer\":\"SCD1 is a key nexus connecting lipid metabolic reprogramming to the regulation of cell death, and it is frequently overexpressed in digestive system malignancies.\"},{\"question\":\"Which regulated cell death pathways are discussed in relation to SCD1?\",\"answer\":\"The review describes SCD1’s influence on ferroptosis, autophagy, and apoptosis, linking lipid modification to tumor progression and therapy resistance.\"},{\"question\":\"How are SCD1-targeting therapies currently approached in preclinical research?\",\"answer\":\"Preclinical strategies include both monotherapy and combination approaches that pair SCD1 targeting with ferroptosis inducers, chemotherapeutic agents, or targeted drugs.\"}]","The pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death | PDF",1790090669,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42aede78dceb40636a5037db2568f869.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3070b5b29ea46dd3d09132f2e160d670.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2504893644f634a2b06239a74995b14.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d98d1348f1c650a85293f88efdc6c96.webp",980,1353]